ScholarIQanswers from OpenAlex

Apolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage

PaperCitations, authors & open-access status

Apolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Apolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage have?

ScholarIQcitation count

Apolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage has 49 citations in the OpenAlex counts ScholarIQ stores.

When was Apolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage published?

ScholarIQyear

Apolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage has 2003 year in the ScholarIQ index.

What is the open-access status of Apolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage?

ScholarIQoa status

Apolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage has closed oa status in the ScholarIQ index.

What is the DOI of Apolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage?

ScholarIQdoi

The DOI for Apolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage is on the source record.

What is the PMID of Apolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage?

ScholarIQpmid

The PMID for Apolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage is on the source record.

What is the OpenAlex record for Apolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage?

ScholarIQopenalex

The OpenAlex for Apolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial